Development of a new treatment for Alzheimer's disease and Parkinson's disease using anti-aggregatory beta-synuclein-derived peptides.

Windisch, Manfred

Development of a new treatment for Alzheimer's disease and Parkinson's disease using anti-aggregatory beta-synuclein-derived peptides. [electronic resource] - Journal of molecular neuroscience : MN - 63-9 p. digital

Publication Type: Journal Article

0895-8696

10.1007/s12031-002-0012-8 doi


Alzheimer Disease--drug therapy
Analysis of Variance
Animals
Cerebral Cortex--metabolism
Frontal Lobe--metabolism
Lewy Bodies--metabolism
Mice
Mice, Transgenic
Nerve Tissue Proteins--metabolism
Parietal Lobe--metabolism
Parkinson Disease--drug therapy
Synucleins
alpha-Synuclein
beta-Synuclein